Abstract P1-01-07: The role of18F-Fluoroestradiol (FES) and18F-Fluorodeoxyglucose (FDG) PET imaging in identification of bone metastases in metastatic breast cancer
Sign Up to like & getrecommendations! Published in 2020 at "Cancer Research"
DOI: 10.1158/1538-7445.sabcs19-p1-01-07
Abstract: Background: Bone dominant metastatic breast cancer can be difficult to stage using conventional imaging. 18F-FES is an estrogen analogue PET imaging tracer that measures estrogen receptor (ER) expression at multiple tumor sites simultaneously and predicts… read more here.
Keywords: breast cancer; fes fdg; bone; cancer ... See more keywords
Dual Tracers of 16α-[18F]fluoro-17β-Estradiol and [18F]fluorodeoxyglucose for Prediction of Progression-Free Survival After Fulvestrant Therapy in Patients With HR+/HER2- Metastatic Breast Cancer
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2020.580277
Abstract: Objective The purpose of this study was to employ dual tracers 16α-[18F]fluoro-17β-estradiol (18F-FES) and [18F]fluorodeoxyglucose (18F-FDG) as imaging biomarkers in predicting progression-free survival (PFS) in ER-positive metastatic breast cancer (MBC) patients receiving fulvestrant therapy. Methods… read more here.
Keywords: 18f fes; fes fdg; fulvestrant therapy;